Litt's Drug Eruption & Reaction Manual 26E: 1st Edition (Paperback) book cover

Litt's Drug Eruption & Reaction Manual 26E

1st Edition

Edited by Neil H. Shear

CRC Press

492 pages

Purchasing Options:$ = USD
Paperback: 9780367438845
pub: 2019-11-25
SAVE ~$29.99
Available for pre-order. Item will ship after 25th November 2019
$149.95
$119.96
x
Hardback: 9780367438852
pub: 2019-11-25
SAVE ~$59.98
Available for pre-order. Item will ship after 25th November 2019
$299.90
$239.92
x


FREE Standard Shipping!

Description

Internationally relied upon by medical practitioners for its unparalleled focus on adverse effects and cutaneous reactions, Litt’s Drug Eruption & Reaction Manual is a succinct clinical reference and essential drug-safety tool for patient care. This 26th edition has been comprehensively revised and updated throughout to act as a quick reference, and each entry includes:

* Summaries of numbers of reports and incidence for reactions

* Clinically important and potentially hazardous drug–drug interactions

* Categories of adverse drug reactions, eruptions, and cutaneous reaction patterns

* Essential reference information on prescription and over-the-counter drugs as well as biologics and supplements

The book contains…

* A to Z listing of the 1500 most consulted generic drug and herbal drug profiles, including generic and trade names; pharmaceutical company; indications; half-life; interactions; pregnancy category; and categories of adverse reactions/eruptions, with summaries of number of reports or level of incidence of reaction

* Over 31,000 adverse reactions and drug-eruption listings

* Supplements, vaccines, and other biologics

* Descriptions of important reactions

* List of drugs that cause important reactions

* List of main classes of drugs as a quick clinical reference guide

* 26 tables showing the reaction profile for members of a class of drugs (such as ACE inhibitors or statins), enabling a clinician to see at a glance whether a reaction is common to all drugs included in that class, or to a majority of them, or is known in only a handful—this information can be used as the basis for an informed decision to change drugs inside the same class

* 2 tables showing reported genetic associations with cutaneous adverse drug reactions and recommendations regarding genetic screening to prevent cutaneous adverse drug reactions

* A concordance of synonyms and trade names for ease of cross-reference

Table of Contents

Introductory notes

Drug profiles: generic names

Descriptions of important reactions

Drugs that cause important reactions

Main classes of drugs

Class reactions

ACE inhibitors

Antiarrhythmics

Antibiotics, imidazole

Antibiotics, macrolide

Anticonvulsants

Antidepressants, tricyclic

Antihistamines (H1)

Antimalarials

Antipsychotics

Antiretrovirals

Benzodiazepines

Beta blockers

Biologics

Bisphosphonates

Calcium channel blockers

Cephalosporins

Corticosteroids, topical

Disease-modifying antirheumatic drugs (DMARDS)

DPP-4 inhibitors

Epidermal growth factor receptor (EGFR) inhibitors

Fluoroquinolones

Non-steroidal anti-inflammatory drugs (NSAIDS)

Proton pump inhibitors (PPI)

Statins

TNF inhibitors

Tyrosine-kinase inhibitors

Genetic tables

Concordance of synonyms and trade names with

generic names

About the Editor

Neil Shear, MD, FRCPC, is Head of Dermatology at Sunnybrook & Women’s College Health Sciences Centre and Director of the University of Toronto Drug Safety Research Group. He founded the Drug Safety Clinic at Sunnybrook in 1985 and was the founding chair of the Canadian Adverse Drug Reaction Advisory Committee (CADRAC) of Health Canada.

Subject Categories

BISAC Subject Codes/Headings:
MED000000
MEDICAL / General
MED017000
MEDICAL / Dermatology
MED029000
MEDICAL / Family & General Practice
MED071000
MEDICAL / Pharmacology